SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-006108
Filing Date
2021-02-25
Accepted
2021-02-25 08:29:41
Documents
17
Period of Report
2021-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10020763x2_8k.htm   iXBRL 8-K 36766
2 EXHIBIT 5.1 nt10020763x2_ex5-1.htm EX-5.1 13518
3 EXHIBIT 10.1 nt10020763x2_ex10-1.htm EX-10.1 283275
4 EXHIBIT 99.1 nt10020763x2_ex99-1.htm EX-99.1 218704
8 nt10020763x2_ex5-1img001.jpg GRAPHIC 8451
9 nt10020763x2_ex99-1img001.jpg GRAPHIC 62050
  Complete submission text file 0001140361-21-006108.txt   873853

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA insm-20210225.xsd EX-101.SCH 4189
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20210225_lab.xml EX-101.LAB 22718
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20210225_pre.xml EX-101.PRE 16212
10 EXTRACTED XBRL INSTANCE DOCUMENT nt10020763x2_8k_htm.xml XML 4071
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 21676569
SIC: 2834 Pharmaceutical Preparations